1.
Closing the case of APOE in multiple sclerosis: no association with disease risk in over 29 000 subjects
by Lill, Christina M
Journal of medical genetics, 2012-09, Vol.49 (9), p.558-562
2.
Genetic risk factors for cerebral small-vessel disease in hypertensive patients from a genetically isolated population
by Schuur, M
Journal of neurology, neurosurgery and psychiatry, 2011-01, Vol.82 (1), p.41-4
3.
Gene-centric Association Signals for Lipids and Apolipoproteins Identified via the HumanCVD BeadChip
by Talmud, Philippa J
American journal of human genetics, 2009-11-13, Vol.85 (5), p.628-642
4.
Genetic associations in diabetic nephropathy: a meta-analysis
by Mooyaart, A. L
Diabetologia, 2010-12-03, Vol.54 (3), p.544-553
5.
Estrogen use and early onset Alzheimer's disease: a population-based study
by Slooter, Arjen J C
Journal of neurology, neurosurgery and psychiatry, 1999-12, Vol.67 (6), p.779-297
6.
GLP-1 Receptor Activation Indirectly Reduces Hepatic Lipid Accumulation But Does Not Attenuate Development of Atherosclerosis in Diabetic Male ApoE−/− Mice
by Panjwani, Naim
Endocrinology (Philadelphia), 2013-01, Vol.154 (1), p.127-139
7.
Genome-wide Association Analysis Reveals Putative Alzheimer's Disease Susceptibility Loci in Addition to APOE
by Bertram, Lars
American journal of human genetics, 2008-11-17, Vol.83 (5), p.623-632
8.
Treatment of diabetes and atherosclerosis by inhibiting fatty-acid-binding protein aP2
by Makowski, Liza
Nature, 2007-07-21, Vol.447 (7147), p.959-965
9.
Anagliptin, a DPP-4 Inhibitor, Suppresses Proliferation of Vascular Smooth Muscles and Monocyte Inflammatory Reaction and Attenuates Atherosclerosis in Male apo E-Deficient Mice
by Ervinna, Nasib
Endocrinology (Philadelphia), 2013-03, Vol.154 (3), p.1260-1270
10.
Native incretins prevent the development of atherosclerotic lesions in apolipoprotein E knockout mice
by Nagashima, M
Diabetologia, 2011-07-24, Vol.54 (10), p.2649-2659
11.
Rosiglitazone Monotherapy in Mild-to-Moderate Alzheimer’s Disease: Results from a Randomized, Double-Blind, Placebo-Controlled Phase III Study
by Gold, Michael
Dementia and geriatric cognitive disorders, 2010-09, Vol.30 (2), p.131-146
12.
Apolipoprotein-mediated pathways of lipid antigen presentation
by Brenner, Michael B
Nature, 2005-10-06, Vol.437 (7060), p.906-910
13.
Androgen Receptor-Dependent and Independent Atheroprotection by Testosterone in Male Mice
by Bourghardt, Johan
Endocrinology (Philadelphia), 2010-11, Vol.151 (11), p.5428-5437
14.
Plasma apolipoprotein A5 and triglycerides in type 2 diabetes
by Dallinga-Thie, G. M
Diabetologia, 2006, Vol.49 (7), p.1505-1511
15.
Low dose oral cannabinoid therapy reduces progression of atherosclerosis in mice
by Mach, François
Nature, 2005-04-07, Vol.434 (7034), p.782-786
16.
TNF-related apoptosis-inducing ligand (TRAIL) protects against diabetes and atherosclerosis in Apoe−/− mice
by Di Bartolo, B. A
Diabetologia, 2011-10-01, Vol.54 (12), p.3157-3167
17.
Polymorphisms in C2, CFB and C3 are associated with progression to advanced age related macular degeneration associated with visual loss
by Francis, P J
Journal of medical genetics, 2009-05, Vol.46 (5), p.300-307
18.
Apolipoprotein E Variation at the Sequence Haplotype Level: Implications for the Origin and Maintenance of a Major Human Polymorphism
by Fullerton, Stephanie M
American journal of human genetics, 2000, Vol.67 (4), p.881-900
19.
Elucidating the Role of Gonadal Hormones in Sexually Dimorphic Gene Coexpression Networks
by van Nas, Atila
Endocrinology (Philadelphia), 2009-03, Vol.150 (3), p.1235-1249
20.
Dysexecutive versus amnesic phenotypes of very mild Alzheimer's disease are associated with distinct clinical, genetic and cortical thinning characteristics
by Dickerson, Bradford C
Journal of neurology, neurosurgery and psychiatry, 2011-01, Vol.82 (1), p.45-51
Filter electronic articles 661 Hits
Remove Filters
- Subjects
- Biological And Medical Sciences
- Humans (590)
- Science & Technology (588)
- more ...